TrialCancer2010

A phase 2 pilot trial of low-dose, continuous infusion, or "metronomic" paclitaxel and oral celecoxib in patients with metastatic melanoma.

Rupal S Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.